Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 455

1.

Adaptation of energy metabolism in breast cancer brain metastases.

Chen EI, Hewel J, Krueger JS, Tiraby C, Weber MR, Kralli A, Becker K, Yates JR 3rd, Felding-Habermann B.

Cancer Res. 2007 Feb 15;67(4):1472-86.

2.

Targeting aspartate aminotransferase in breast cancer.

Thornburg JM, Nelson KK, Clem BF, Lane AN, Arumugam S, Simmons A, Eaton JW, Telang S, Chesney J.

Breast Cancer Res. 2008;10(5):R84. doi: 10.1186/bcr2154.

3.

Integrin activation controls metastasis in human breast cancer.

Felding-Habermann B, O'Toole TE, Smith JW, Fransvea E, Ruggeri ZM, Ginsberg MH, Hughes PE, Pampori N, Shattil SJ, Saven A, Mueller BM.

Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1853-8.

4.

Breast cancer metastasis in a human bone NOD/SCID mouse model.

Yang W, Lam P, Kitching R, Kahn HJ, Yee A, Aubin JE, Seth A.

Cancer Biol Ther. 2007 Aug;6(8):1289-94.

PMID:
17704641
5.

Mitochondrial bioenergetic adaptations of breast cancer cells to aglycemia and hypoxia.

Smolková K, Bellance N, Scandurra F, Génot E, Gnaiger E, Plecitá-Hlavatá L, Jezek P, Rossignol R.

J Bioenerg Biomembr. 2010 Feb;42(1):55-67. doi: 10.1007/s10863-009-9267-x.

PMID:
20084539
6.

Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism.

Pathania D, Millard M, Neamati N.

Adv Drug Deliv Rev. 2009 Nov 30;61(14):1250-75. doi: 10.1016/j.addr.2009.05.010. Review.

PMID:
19716393
7.

Imagable 4T1 model for the study of late stage breast cancer.

Tao K, Fang M, Alroy J, Sahagian GG.

BMC Cancer. 2008 Aug 9;8:228. doi: 10.1186/1471-2407-8-228.

8.

Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain.

Palmieri D, Bronder JL, Herring JM, Yoneda T, Weil RJ, Stark AM, Kurek R, Vega-Valle E, Feigenbaum L, Halverson D, Vortmeyer AO, Steinberg SM, Aldape K, Steeg PS.

Cancer Res. 2007 May 1;67(9):4190-8.

9.

Estradiol stimulates the biosynthetic pathways of breast cancer cells: detection by metabolic flux analysis.

Forbes NS, Meadows AL, Clark DS, Blanch HW.

Metab Eng. 2006 Nov;8(6):639-52.

PMID:
16904360
10.

Metabolic and morphological differences between rapidly proliferating cancerous and normal breast epithelial cells.

Meadows AL, Kong B, Berdichevsky M, Roy S, Rosiva R, Blanch HW, Clark DS.

Biotechnol Prog. 2008 Mar-Apr;24(2):334-41. doi: 10.1021/bp070301d.

PMID:
18307352
11.

Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells.

Wu M, Neilson A, Swift AL, Moran R, Tamagnine J, Parslow D, Armistead S, Lemire K, Orrell J, Teich J, Chomicz S, Ferrick DA.

Am J Physiol Cell Physiol. 2007 Jan;292(1):C125-36.

12.

Protein pathway activation mapping of brain metastasis from lung and breast cancers reveals organ type specific drug target activation.

Improta G, Zupa A, Fillmore H, Deng J, Aieta M, Musto P, Liotta LA, Broaddus W, Petricoin EF 3rd, Wulfkuhle JD.

J Proteome Res. 2011 Jul 1;10(7):3089-97. doi: 10.1021/pr200065t.

PMID:
21574647
13.

Metabolism and brain cancer.

Marie SK, Shinjo SM.

Clinics (Sao Paulo). 2011;66 Suppl 1:33-43. Review.

14.

Role of natural killer cells in hormone-independent rapid tumor formation and spontaneous metastasis of breast cancer cells in vivo.

Dewan MZ, Terunuma H, Takada M, Tanaka Y, Abe H, Sata T, Toi M, Yamamoto N.

Breast Cancer Res Treat. 2007 Sep;104(3):267-75.

PMID:
17066321
15.

Oxidative metabolism in cancer growth.

Ristow M.

Curr Opin Clin Nutr Metab Care. 2006 Jul;9(4):339-45. Review.

PMID:
16778561
16.

Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer.

Li HZ, Gao Y, Zhao XL, Liu YX, Sun BC, Yang J, Yao Z.

Mol Cancer Res. 2009 Jun;7(6):832-40. doi: 10.1158/1541-7786.MCR-08-0403.

17.

A mouse model of human breast cancer metastasis to human bone.

Kuperwasser C, Dessain S, Bierbaum BE, Garnet D, Sperandio K, Gauvin GP, Naber SP, Weinberg RA, Rosenblatt M.

Cancer Res. 2005 Jul 15;65(14):6130-8.

18.

In vivo xenograft models of breast cancer metastasis.

Valentiner U, Brooks SA, Schumacher U.

Methods Mol Med. 2006;120:479-88.

PMID:
16491620
19.

Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.

Mitra A, Fillmore RA, Metge BJ, Rajesh M, Xi Y, King J, Ju J, Pannell L, Shevde LA, Samant RS.

Breast Cancer Res. 2008;10(2):R22. doi: 10.1186/bcr1874.

20.

A highly bone marrow metastatic murine breast cancer model established through in vivo selection exhibits enhanced anchorage-independent growth and cell migration mediated by ICAM-1.

Takahashi M, Furihata M, Akimitsu N, Watanabe M, Kaul S, Yumoto N, Okada T.

Clin Exp Metastasis. 2008;25(5):517-29. doi: 10.1007/s10585-008-9163-5.

PMID:
18340424
Items per page

Supplemental Content

Support Center